Progress in the cell cycle is governed by the activity of cyclin dependent
kinases (Cdks). Unlike other Cdks, the Cdk5 catalytic subunit is found most
ly in differentiated neurons. Interestingly, the only known protein that ac
tivates Cdk5 (i.e. p35) is expressed solely in the brain. It has been sugge
sted that, besides its requirement in neuronal differentiation, Cdk5 activi
ty is induced during myogenesis. However, it is not clear how this activity
is regulated in the pathway that leads proliferative cells to differentiat
ion. Tn order to find if there exists any Cdk5-interacting protein, the yea
st two-hybrid system was used to screen a HeLa cDNA library. We have determ
ined that a C-terminal 172 amino acid domain of the DNA binding protein, db
pA, binds to Cdk5. Biochemical analyses reveal that this fragment (dbpA(C D
elta)) strongly inhibits p35-activated Cdk5 kinase. The protein also intera
cts with Cdk4 and inhibits the Cdk4/cyclin D1 enzyme. Surprisingly, dbpA(C
Delta) does not bind Cdk2 in the two-hybrid assay nor does it inhibit Cdk2
activated by cyclin A. It could be that dbpA's ability to inhibit Cdk5 and
Cdk5 reflects an apparent cross-talk between distinct signal transduction p
athways controlled by dbpA on the one hand and Cdk5 or Cdk4 on the other. (
C) 1999 Federation of European Biochemical Societies.